Pulike Biological Engineering, Inc. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 821.02 million compared to CNY 647.43 million a year ago. Revenue was CNY 821.02 million compared to CNY 647.43 million a year ago. Net income was CNY 230.63 million compared to CNY 160.47 million a year ago. Basic earnings per share from continuing operations was CNY 0.73 compared to CNY 0.51 a year ago. Diluted earnings per share from continuing operations was CNY 0.73 compared to CNY 0.51 a year ago.